AbbVie's $1.4B Campus: 734 Jobs, 2028 Completion

0:00It's April 22nd. This is Durham News Today, powered by AI. Avi just dropped a massive $1.4 billion investment to build a cutting-edge pharmaceutical manufacturing campus on 100, 85 acres in Durham, North Carolina. This spot will crank out meds for immunology, neuroscience, and oncology, bringing 734 new jobs like engineers, scientists, operators, and lab techs over the next four years, plus over 2,000 construction gigs during the build. Construction kicks off this year. Amy for completion by the end of 2028, marking Abbey's biggest single-campus bet ever. They picked Durham for its killer workforce and room to grow, turning the bull city into a hub for their pipeline. Local leaders are hyped, calling it the largest private investment in Durham's history, and a game-changer for shared growth. The mayor sees it as proof the city's winning on the global stage, while county commissioners praise the entry-level jobs opening doors to real, economic mobility for residents.

1:02The first phase rolls out small-volume, parental drug facilities, next-gen labs, a warehouse, offices, and wellness spots to keep the team sharp. Once done, it'll be Abbey's U.S. Center of Excellence for their manufacturing, shipping breakthrough treatments worldwide. This move locks in long-term jobs and innovation for Durham, boosting the whole region's economy for years ahead.